G007-LK
| 中文名稱 | G007-LK |
|---|---|
| 中文同義詞 | 4-[5-[(1E)-2-[4-(2-氯苯基)-5-[5-(甲基磺?；?-2-吡啶基]-4H-1,2,4-三唑-3-基]乙烯基]-1,3,4-惡二唑-2-基]苯甲腈;TANKYRASE抑制劑(G007-LK);G007-LK游離態(tài);G007-LK游離;化合物G007-LK;(E)-4-(5-(2-(4-(2-氯苯基)-5-(5-(甲磺?；?吡啶-2-基)-4H-1,2,4-三唑-3-基)乙烯基)-1,3,4-惡二唑-2-基)苯甲腈;化合物G007-LK,10 MM DMSO 溶液;化合物:G007-LK CAS:1380672-07-0 |
| 英文名稱 | G007-LK |
| 英文同義詞 | G007-LK;(E)-4-(5-(2-(4-(2-chlorophenyl)-5-(5-(methylsulfonyl)pyridin-2-yl)-4H-1,2,4-triazol-3-yl)vinyl)-1,3,4-oxadiazol-2-yl)benzonitrile;4-[5-[(1E)-2-[4-(2-Chlorophenyl)-5-[5-(methylsulfonyl)-2-pyridinyl]-4H-1,2,4-triazol-3-yl]ethenyl]-1,3,4-oxadiazol-2-yl]benzonitrile;Benzonitrile, 4-[5-[(1E)-2-[4-(2-chlorophenyl)-5-[5-(methylsulfonyl)-2-pyridinyl]-4H-1,2,4-triazol-3-yl]ethenyl]-1,3,4-oxadiazol-2-yl]-;G007-LK;G007 LK;G007LK;CS-1659;Tankyrase 1/2 Inhibitor VI, G007-LK - Calbiochem;G007 LK;G007LK |
| CAS號(hào) | 1380672-07-0 |
| 分子式 | C25H16ClN7O3S |
| 分子量 | 529.96 |
| EINECS號(hào) | |
| 相關(guān)類別 | 細(xì)胞生物學(xué)試劑 |
| Mol文件 | 1380672-07-0.mol |
| 結(jié)構(gòu)式 |  |
G007-LK 性質(zhì)
| 沸點(diǎn) | 817.3±75.0 °C(Predicted) |
|---|---|
| 密度 | 1.47±0.1 g/cm3(Predicted) |
| 儲(chǔ)存條件 | +2C to +8C |
| 溶解度 | DMSO 中≥26.5 mg/mL；不溶于水；不溶于乙醇 |
| 形態(tài) | 白色粉末 |
| 酸度系數(shù)(pKa) | -1.68±0.10(Predicted) |
| 顏色 | 米白色至黃色 |
| InChI | 1S/C25H16ClN7O3S/c1-37(34,35)18-10-11-20(28-15-18)24-31-29-22(33(24)21-5-3-2-4-19(21)26)12-13-23-30-32-25(36-23)17-8-6-16(14-27)7-9-17/h2-13,15H,1H3/b13-12+ |
| InChIKey | HIWVLHPKZNBSBE-OUKQBFOZSA-N |
| SMILES | [S](=O)(=O)(C)c1cnc(cc1)c2[n](c(nn2)\C=C\c4nnc([o]4)c5ccc(cc5)C#N)c3c(cccc3)Cl |
| Target | Value |
|
TNKS2
(Cell-free assay) | 25 nM |
|
TNKS1
(Cell-free assay) | 46 nM |
G007-LK is a potent inhibitor of TNKS1 and TNKS2, with IC 50 s of 46 nM and 25 nM, respectively, and a cellular IC 50 of 50 nM. G007-LK shows no inhibition of PARP1 at doses up to 20 μM, and has a high CYP3A4 inhibition IC 50 value (>25 μM). G007-LK (0-20 μM) dose-dependently inhibits hepatocellular carcinoma (HCC) cell growth. G007-LK also downregulates the levels of YAP by upregulating AMOTL1 and AMOTL2 in HCC cell lines. In addition, G007-LK (0-20 μM) synergizes with MEK and AKT inhibitors to suppress HCC cell proliferation.
G007-LK displays great pharmacokinetic profile in ICR mice. G007-LK (100 mg/kg chow, p.o.) significantly reduces lineage tracing from LGR5 + intestinal stem cells in mice. G007-LK (100 mg/kg chow, p.o.) specifically targets LGR5 + WNT-dependent intestinal stem cells in Lgr5-EGFP-CreERT2;R26R-tdTomato mice. G007-LK (10, 50 mg/kg, p.o.) also suppressses canonical WNT signalling. Furthermore, G007-LK (100, 1000 mg/kg chow, p.o) shows no effect on the alteration of duodenal morphology.
安全信息
| WGK Germany | WGK 2 |
|---|---|
| 存儲(chǔ)類別 | 11 - 可燃固體 |
| 更新日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
|---|---|---|---|---|---|
| 2026/07/06 | S7239 | G007-LK G007-LK | 1380672-07-0 | 5mg | 1188.88元 |
| 2026/07/06 | S7239 | G007-LK G007-LK | 1380672-07-0 | 10mM(1mL in DMSO) | 2203.11元 |